1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Hua, Q.X.
Liu, M.
Hu, S.Q.
Jia, W.
Arvan, P.
Weiss, M.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
281
24889
24899
10.1074/jbc.M602617200
16728398
A Conserved Histidine in Insulin Is Required for the Foldability of Human Proinsulin: Structure and function of an Alab5 analog.
2006
10.2210/pdb2h67/pdb
pdb_00002h67
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
2383.698
Insulin A chain
1
man
polymer
3343.825
Insulin B chain
H29A,H34D,P52K, K53P
1
man
polymer
no
no
GIVEQCCTSICSLYQLENYCN
GIVEQCCTSICSLYQLENYCN
A
polypeptide(L)
no
no
FVNQALCGSDLVEALYLVCGERGFFYTKPT
FVNQALCGSDLVEALYLVCGERGFFYTKPT
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
INS
9606
Homo sapiens
562
Escherichia coli
human
Homo
Escherichia
sample
INS
9606
Homo sapiens
562
Escherichia coli
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2006-07-18
1
1
2008-05-01
1
2
2011-07-13
1
3
2021-10-20
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
RCSB
Y
RCSB
2006-05-30
REL
REL
THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR NMR TECHNIQUES.
structures with the lowest energy
40
20
2D TOCSY
NOESY
COSY
7.0
298
K
8.0
305
K
20% acetic acid
2.0
298
K
RMSD VALUES FOR ALL 20 STRUCTURES VERSUS GEOMETRIC AVERAGE: (BACKBONE, A2-A20, B4-B24) 0.49 ANGSTROM
DISTANCE GEOMETRY AND SIMULATED ANNEALING
1
lowest energy
BRUNGER
refinement
X-PLOR
3.85
BRUNGER
refinement
CNS
1.1
Bruker
processing
XwinNMR
3.5
700
Bruker
DRX
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
PHE
1
n
1
PHE
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
ALA
5
n
5
ALA
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
ASP
10
n
10
ASP
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
LYS
28
n
28
LYS
28
B
PRO
29
n
29
PRO
29
B
THR
30
n
30
THR
30
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
B
B
O
H
VAL
TYR
12
16
1.43
1
B
B
O
H
SER
GLU
9
13
1.44
1
A
A
O
H
VAL
CYS
3
7
1.45
2
B
B
O
H
VAL
TYR
12
16
1.46
2
A
A
O
HG1
GLU
THR
4
8
1.46
2
A
A
O
H
VAL
CYS
3
7
1.46
2
B
B
O
H
SER
GLU
9
13
1.53
2
B
B
O
H
LEU
LEU
11
15
1.55
3
B
B
O
H
LEU
LEU
11
15
1.45
3
B
B
O
H
LEU
VAL
15
18
1.45
4
B
B
O
H
LEU
LEU
11
15
1.58
5
B
B
O
H
VAL
TYR
12
16
1.38
5
B
B
O
H
SER
GLU
9
13
1.50
5
B
B
O
H
LEU
CYS
15
19
1.51
5
A
B
H
O
ASN
GLY
21
23
1.59
7
B
B
O
H
VAL
TYR
12
16
1.40
7
A
A
O
H
VAL
CYS
3
7
1.50
7
B
B
O
H
SER
GLU
9
13
1.53
9
B
B
O
H
VAL
TYR
12
16
1.36
9
B
B
O
H
SER
GLU
9
13
1.53
10
B
B
O
H
VAL
TYR
12
16
1.40
10
B
B
O
H
LEU
LEU
11
15
1.48
10
B
B
O
H
SER
GLU
9
13
1.49
10
A
A
O
H
ILE
GLN
2
5
1.53
10
B
B
O
H
LEU
CYS
15
19
1.57
11
B
B
O
H
VAL
TYR
12
16
1.46
11
B
B
O
H
SER
GLU
9
13
1.47
11
B
B
O
H
LEU
LEU
11
15
1.57
12
A
A
O
H
SER
GLN
12
15
1.60
13
A
A
O
H
VAL
CYS
3
7
1.55
13
B
B
O
H
LEU
LEU
11
15
1.60
14
B
B
O
H
SER
GLU
9
13
1.49
14
B
B
O
H
LEU
LEU
11
15
1.53
14
A
A
O
H
VAL
CYS
3
7
1.55
16
A
A
O
H
VAL
CYS
3
7
1.55
17
A
A
O
H
SER
GLN
12
15
1.60
18
A
A
O
H
VAL
CYS
3
7
1.55
18
B
B
O
H
LEU
LEU
11
15
1.60
19
A
A
O
H
VAL
CYS
3
7
1.57
20
B
B
O
H
CYS
ARG
19
22
1.52
20
B
B
O
H
LEU
LEU
11
15
1.54
20
B
B
O
H
VAL
TYR
12
16
1.57
1
B
ARG
22
0.274
SIDE CHAIN
2
B
ARG
22
0.245
SIDE CHAIN
3
B
ARG
22
0.122
SIDE CHAIN
5
B
ARG
22
0.315
SIDE CHAIN
7
B
ARG
22
0.313
SIDE CHAIN
9
B
ARG
22
0.213
SIDE CHAIN
10
B
ARG
22
0.271
SIDE CHAIN
11
B
ARG
22
0.286
SIDE CHAIN
13
B
ARG
22
0.094
SIDE CHAIN
14
B
ARG
22
0.302
SIDE CHAIN
18
B
ARG
22
0.094
SIDE CHAIN
20
B
ARG
22
0.317
SIDE CHAIN
3
-29.66
2.10
120.10
90.44
A
A
A
CA
C
O
ASN
ASN
ASN
21
21
21
N
14
-22.60
2.10
120.10
97.50
A
A
A
CA
C
O
ASN
ASN
ASN
21
21
21
N
20
-15.35
2.10
120.10
104.75
A
A
A
CA
C
O
ASN
ASN
ASN
21
21
21
N
14
A
A
C
O
ASN
ASN
21
21
0.140
0.019
1.229
1.369
N
1
A
GLU
4
-36.40
-34.86
1
A
CYS
7
-78.16
-76.04
1
A
THR
8
-55.86
-87.19
1
A
SER
9
-49.37
173.46
1
A
CYS
20
-49.89
178.89
1
B
LEU
11
-66.69
-73.45
1
B
CYS
19
-107.03
-73.25
1
B
LYS
28
172.18
124.04
2
A
THR
8
-61.89
-83.63
2
A
SER
9
-57.67
-163.20
2
B
LEU
11
-68.29
-70.82
3
A
GLN
5
-100.32
-66.04
3
A
SER
9
75.65
-140.76
3
B
VAL
2
-127.03
-167.71
3
B
ALA
5
-59.59
177.30
3
B
TYR
16
-39.13
-31.63
3
B
GLU
21
75.54
-8.03
3
B
LYS
28
160.44
-49.19
4
A
GLN
5
-63.27
-78.51
4
A
SER
9
-177.82
-175.10
4
B
VAL
2
-107.80
-159.63
4
B
ASN
3
-93.27
43.36
4
B
ALA
5
-72.81
-166.98
4
B
LEU
6
-165.66
108.19
4
B
LEU
11
-76.06
-70.60
4
B
GLU
21
77.96
-0.95
4
B
PHE
25
-98.25
-82.16
4
B
TYR
26
38.44
75.36
4
B
PRO
29
-59.59
170.91
5
B
ALA
5
-68.17
-164.70
5
B
LEU
6
-160.18
105.99
6
A
ILE
2
-39.77
-33.17
6
A
VAL
3
-90.74
-75.29
6
A
GLU
4
-39.52
-30.89
6
A
GLN
5
-88.79
-71.37
6
A
THR
8
-84.43
-85.13
6
A
CYS
11
-41.19
163.23
6
A
CYS
20
-55.40
109.99
6
B
VAL
2
-154.79
-154.13
6
B
ALA
5
-134.49
-53.85
6
B
LEU
6
65.09
87.43
6
B
PHE
24
-54.37
177.31
6
B
PHE
25
-101.46
-84.12
6
B
TYR
26
35.01
72.23
6
B
LYS
28
-148.98
50.54
7
A
GLU
4
-38.77
-31.09
7
A
GLN
5
-68.91
-78.56
7
A
SER
9
69.54
-177.38
7
A
CYS
20
-48.74
153.79
7
B
ALA
5
-64.36
-176.94
7
B
LEU
11
-51.82
-71.94
7
B
CYS
19
-106.52
-77.32
7
B
PHE
24
-160.81
-158.60
7
B
PHE
25
173.46
83.22
7
B
TYR
26
-72.91
-76.39
7
B
LYS
28
179.14
138.23
8
A
THR
8
-21.77
-56.47
8
B
ASN
3
-103.32
53.65
8
B
ALA
5
-59.11
-165.05
8
B
LEU
6
-134.11
-56.74
8
B
CYS
7
-31.24
148.50
8
B
LEU
11
-80.77
-77.02
8
B
CYS
19
-91.93
-65.01
8
B
TYR
26
-62.66
88.99
8
B
PRO
29
-66.72
20.64
9
A
SER
9
58.67
-163.06
9
B
LEU
11
-71.65
-70.37
9
B
GLU
21
78.31
-5.50
10
A
VAL
3
-23.65
-47.71
10
A
GLU
4
-38.80
-27.89
10
A
GLN
5
-105.98
-60.64
10
A
SER
9
58.12
-167.35
10
B
VAL
2
-157.47
-151.41
10
B
ASN
3
82.32
31.77
10
B
LEU
11
-67.45
-74.22
10
B
CYS
19
-106.25
-78.27
10
B
LYS
28
163.46
-47.31
11
A
THR
8
-61.45
-131.50
11
A
SER
9
-45.02
-99.86
11
B
VAL
2
-79.33
-150.80
11
B
ALA
5
-173.88
127.98
11
B
LEU
6
-113.67
75.93
11
B
CYS
19
-103.67
-75.57
11
B
LYS
28
66.64
82.24
12
A
SER
9
61.84
-160.41
12
B
GLN
4
-75.94
-163.35
12
B
ALA
5
-138.35
-46.87
12
B
LEU
6
72.72
77.57
12
B
LEU
11
-74.41
-70.24
12
B
LEU
15
-90.24
-62.37
12
B
GLU
21
83.70
-16.88
12
B
PHE
24
46.73
172.52
12
B
PHE
25
-119.58
-81.36
12
B
TYR
26
42.41
81.53
12
B
LYS
28
-52.51
177.44
13
A
ILE
2
179.10
-46.09
13
A
SER
9
-118.86
-166.25
13
B
ASN
3
-94.39
41.44
13
B
LEU
15
-77.65
-72.79
13
B
ARG
22
-9.34
-73.30
13
B
PHE
24
35.22
-163.31
13
B
TYR
26
-68.68
69.80
13
B
LYS
28
-134.37
-57.05
14
A
SER
9
-133.06
-141.74
14
B
VAL
2
-120.20
-166.52
14
B
PHE
25
-143.56
43.67
14
B
LYS
28
63.46
106.49
14
B
PRO
29
-76.94
-169.68
15
A
ILE
2
33.12
77.24
15
A
GLU
4
-38.98
-33.06
15
A
GLN
5
-91.31
-70.88
15
A
CYS
7
-63.95
77.33
15
A
THR
8
-177.32
-48.28
15
A
CYS
20
-38.42
107.03
15
B
ASN
3
-90.82
51.62
15
B
GLN
4
-73.54
-153.31
15
B
ALA
5
-154.67
-46.86
15
B
LEU
6
83.28
82.98
15
B
LEU
11
-68.93
-75.74
15
B
LEU
15
-90.09
-64.97
15
B
ARG
22
-108.09
69.36
15
B
PHE
24
-55.28
-178.34
15
B
PHE
25
-131.55
-84.79
15
B
TYR
26
68.59
-29.08
16
A
ILE
2
18.11
57.39
16
A
GLN
5
-91.42
-61.01
16
A
SER
9
-135.24
-158.85
16
A
ILE
10
-105.22
78.17
16
B
VAL
2
-133.48
-158.84
16
B
ASN
3
-85.59
49.89
16
B
GLN
4
-70.83
-139.28
16
B
ALA
5
-160.69
-47.53
16
B
LEU
6
81.91
83.51
16
B
LEU
11
-63.39
-76.26
16
B
LEU
15
-90.21
-63.41
16
B
PHE
24
49.53
-172.07
16
B
PHE
25
-114.59
-83.78
16
B
TYR
26
44.03
84.62
16
B
LYS
28
-179.87
-49.81
17
A
SER
9
61.79
-160.44
17
B
GLN
4
-75.98
-163.42
17
B
ALA
5
-138.31
-46.86
17
B
LEU
6
72.74
77.59
17
B
LEU
11
-74.37
-70.36
17
B
LEU
15
-90.19
-62.34
17
B
GLU
21
83.76
-16.91
17
B
PHE
24
46.83
172.52
17
B
PHE
25
-119.64
-81.33
17
B
TYR
26
42.47
81.49
17
B
LYS
28
-52.50
177.43
18
A
ILE
2
179.11
-46.13
18
A
SER
9
-118.85
-166.26
18
B
ASN
3
-94.39
41.46
18
B
LEU
15
-77.65
-72.79
18
B
ARG
22
-9.31
-73.30
18
B
PHE
24
35.15
-163.30
18
B
TYR
26
-68.63
69.81
18
B
LYS
28
-134.29
-57.06
19
A
VAL
3
-46.35
-70.62
19
B
GLN
4
-76.22
-162.14
19
B
ALA
5
-148.94
-49.12
19
B
LEU
6
73.40
75.24
19
B
LEU
11
-69.45
-73.60
19
B
PHE
25
-106.70
-75.01
19
B
TYR
26
55.90
109.01
19
B
PRO
29
-65.56
10.37
20
A
THR
8
-37.95
-95.30
20
A
SER
9
-88.03
-108.21
20
A
CYS
11
-54.28
-162.20
20
B
GLN
4
35.81
-157.94
20
B
ALA
5
87.42
109.14
20
B
PHE
25
-144.45
28.93
20
B
LYS
28
158.06
132.07
NMR structure of human insulin mutant HIS-B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures
1
N
N
2
N
N
A
GLY
1
A
GLY
1
HELX_P
A
CYS
7
A
CYS
7
1
1
7
A
SER
12
A
SER
12
HELX_P
A
GLU
17
A
GLU
17
1
2
6
B
CYS
7
B
CYS
7
HELX_P
B
CYS
19
B
CYS
19
1
3
13
disulf
2.017
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.018
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
2.016
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
HORMONE/GROWTH FACTOR
HORMONE, HUMAN INSULIN, MUTANT, HORMONE-GROWTH FACTOR COMPLEX
INS_HUMAN
UNP
1
90
P01308
GIVEQCCTSICSLYQLENYCN
INS_HUMAN
UNP
2
25
P01308
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
90
110
2H67
1
21
P01308
A
1
1
21
25
54
2H67
1
30
P01308
B
2
1
30
2
HIS
engineered mutation
ALA
5
2H67
B
P01308
UNP
29
5
2
HIS
engineered mutation
ASP
10
2H67
B
P01308
UNP
34
10
2
PRO
engineered mutation
LYS
28
2H67
B
P01308
UNP
52
28
2
LYS
engineered mutation
PRO
29
2H67
B
P01308
UNP
53
29